Correlation Between Praxis Precision and Adaptimmune Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Praxis Precision and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Adaptimmune Therapeutics.

Diversification Opportunities for Praxis Precision and Adaptimmune Therapeutics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Praxis and Adaptimmune is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and Adaptimmune Therapeutics go up and down completely randomly.

Pair Corralation between Praxis Precision and Adaptimmune Therapeutics

Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.78 times more return on investment than Adaptimmune Therapeutics. However, Praxis Precision Medicines is 1.28 times less risky than Adaptimmune Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.06 per unit of risk. If you would invest  4,678  in Praxis Precision Medicines on August 27, 2024 and sell it today you would earn a total of  2,772  from holding Praxis Precision Medicines or generate 59.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Adaptimmune Therapeutics Plc

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Adaptimmune Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adaptimmune Therapeutics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Praxis Precision and Adaptimmune Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Adaptimmune Therapeutics

The main advantage of trading using opposite Praxis Precision and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.
The idea behind Praxis Precision Medicines and Adaptimmune Therapeutics Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges